Product Information
BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0217 per EA under NDC 59651038905. Its NADAC has been published 261 times since Aug 25, 2021.
FDA first approved this application on Feb 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651038905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078246FDA Approved
2/27/2009
TE Code
AB
On Market Since
2/21/2020
Price Statistics
The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 261 times since Aug 25, 2021, and over the history we have for it it has declined 18.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0217 per EA |
|---|---|
| All-time high | $0.0314 (Nov 16, 2022) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0224 |
| 52-week low | $0.0214 |
| Median price | $0.0249 |
| Average price | $0.0248 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 261 |
| Tracking since | Aug 25, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0217 per EA (NDC 59651038905), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 18.3%. It has been tracked across 261 weekly CMS publications since Aug 25, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?
Since Aug 25, 2021, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0249 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 5 MG TABLET?
BUSPIRONE HCL 5 MG TABLET (NDC 59651038905) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.